• English
    • français
  • English 
    • English
    • français
  • Login
View Item 
  •   ADHL Home
  • University of Nairobi ADHL Node
  • Nairobi ADHL
  • View Item
  •   ADHL Home
  • University of Nairobi ADHL Node
  • Nairobi ADHL
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Network model of survival signaling in large granular lymphocyte leukemia

Thumbnail
Date
2008
Author
Zhang, R
Shah, MV
Yang, J
Nyland, SB
et al
Type
Article
Language
en
Metadata
Show full item record

Abstract
T cell large granular lymphocyte (T-LGL) leukemia features a clonal expansion of antigen-primed, competent, cytotoxic T lymphocytes (CTL). To systematically understand signaling components that determine the survival of CTL in T-LGL leukemia, we constructed a T-LGL survival signaling network by integrating the signaling pathways involved in normal CTL activation and the known deregulations of survival signaling in leukemic T-LGL. This network was subsequently translated into a predictive, discrete, dynamic model. Our model suggests that the persistence of IL-15 and PDGF is sufficient to reproduce all known deregulations in leukemic T-LGL. This finding leads to the following predictions: (i) Inhibiting PDGF signaling induces apoptosis in leukemic T-LGL. (ii) Sphingosine kinase 1 and NFkappaB are essential for the long-term survival of CTL in T-LGL leukemia. (iii) NFkappaB functions downstream of PI3K and prevents apoptosis through maintaining the expression of myeloid cell leukemia sequence 1. (iv) T box expressed in T cells (T-bet) should be constitutively activated concurrently with NFkappaB activation to reproduce the leukemic T-LGL phenotype. We validated these predictions experimentally. Our study provides a model describing the signaling network involved in maintaining the long-term survival of competent CTL in humans. The model will be useful in identifying potential therapeutic targets for T-LGL leukemia and generating long-term competent CTL necessary for tumor and cancer vaccine development.
URI
https://library.adhl.africa/handle/123456789/7392
More info.
www.ncbi.nlm.nih.gov/whalecom0/pubmed/18852469
http://hdl.handle.net/11295/30609
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571012/
Citation
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42)
Collections
  • Nairobi ADHL [363]

Copyright © 2019 
The African Digital Health Library (ADHL) | Kenya | Mali | Nigeria | Zambia | Zimbabwe
| Privacy Policy | Send Feedback
 

Browse

All of ADHLCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

View Google Analytics Statistics

Copyright © 2019 
The African Digital Health Library (ADHL) | Kenya | Mali | Nigeria | Zambia | Zimbabwe
| Privacy Policy | Send Feedback